Bionomics Analyst Ratings
Bionomics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 12/19/2022 | — | HC Wainwright & Co. | Downgrades | Buy → Neutral | |
| 11/01/2022 | 238.24% | Loop Capital | → $23 | Initiates Coverage On | → Buy |
| 01/10/2022 | 664.71% | Cantor Fitzgerald | → $52 | Initiates Coverage On | → Overweight |
| 01/10/2022 | 150% | Evercore ISI Group | → $17 | Initiates Coverage On | → Outperform |
| 01/10/2022 | 208.82% | Berenberg | → $21 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 12/19/2022 | — | HC Wainwright公司 | 評級下調 | 購買→中性 | |
| 11/01/2022 | 238.24% | 環路資本 | → $23 | 開始承保 | →購買 |
| 01/10/2022 | 664.71% | 康託·菲茨傑拉德 | → $52 | 開始承保 | →超重 |
| 01/10/2022 | 150% | Evercore ISI集團 | → $17 | 開始承保 | →跑贏大盤 |
| 01/10/2022 | 208.82% | 貝倫伯格 | → $21 | 開始承保 | →購買 |
What is the target price for Bionomics (BNOX)?
生物製藥(BNOX)的目標價是多少？
The latest price target for Bionomics (NASDAQ: BNOX) was reported by HC Wainwright & Co. on December 19, 2022. The analyst firm set a price target for $0.00 expecting BNOX to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.
生物製藥(納斯達克代碼：BNOX)的最新目標價是由HC Wainwright&Co.於2022年12月19日報告的。這家分析公司將目標價定為0.00美元，預計BNOX將在12個月內降至(跌幅可能為-100.00%)。去年有5家分析公司公佈了評級。
What is the most recent analyst rating for Bionomics (BNOX)?
生物學(BNOX)的最新分析師評級是多少？
The latest analyst rating for Bionomics (NASDAQ: BNOX) was provided by HC Wainwright & Co., and Bionomics downgraded their neutral rating.
納斯達克(Sequoia Capital：BNOX)最新分析師評級由HC Wainwright&Co.提供，Bionomics下調中性評級。
When is the next analyst rating going to be posted or updated for Bionomics (BNOX)?
生物學(BNOX)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bionomics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bionomics was filed on December 19, 2022 so you should expect the next rating to be made available sometime around December 19, 2023.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Bionomics的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。生物學的上一次評級是在2022年12月19日提交的，所以你應該預計下一次評級將在2023年12月19日左右提供。
Is the Analyst Rating Bionomics (BNOX) correct?
分析師評級生物學(BNOX)正確嗎？
While ratings are subjective and will change, the latest Bionomics (BNOX) rating was a downgraded with a price target of $0.00 to $0.00. The current price Bionomics (BNOX) is trading at is $6.80, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的生物科技(BNOX)評級被下調，目標價為0.00美元至0.00美元。生物科技(BNOX)目前的交易價格為6.8美元，超出了分析師的預測範圍。
譯文內容由第三人軟體翻譯。